-
Research of an experimental urine test indicates that it successfully diagnoses chlamydia infection in men within the hour, which improves the ability to successfully treat the infection on the spot and prevent retransmission.
-
Get set for possible changes in human papillomavirus (HPV) vaccine use. A Food and Drug Administration (FDA) review committee has voted that clinical data support the efficacy and safety of GlaxoSmithKline's Cervarix vaccine candidate for the prevention of cervical precancers and cervical cancer related to HPV types 16 and 18 in girls and young women.
-
In July 2009, data from the National Vital Statistics System were published presenting a snapshot of the sexual and reproductive health of young people aged 10-24 between 2002 and 2007.
-
Despite the findings of two new studies,1,2 providers should focus on the fact that two earlier, large studies have compared safety data from women using Yasmin (Bayer HealthCare Pharmaceuticals; Wayne, NJ) to that of other oral contraceptive (OC) users,3,4 family planning experts emphasize.
-
Dabigatran vs warfarin: Less bleeding?; Does SHBG increase risk of diabetes?; Effect of CYP2C19 variants on clopidogrel; Denosumab for osteoporosis; CRP and HTN treatment;
-
-
The hand clapping test is a quick and reliable way to screen for parietal lobe neglect syndrome.
-
Biomarkers in the cerebrospinal fluid may help in the early diagnosis of Alzheimer's disease.
-
Anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis has been recognized in children as young as 23 months as well as adolescents.
-
Elevated levels of a specific organochlorine pesticide are associated with Parkinson's disease.